The current price of LQDA is $47.38 — it has increased by 12.27% since the previous close. Data as of Nov 4, 2026.
LQDA is up 6.33% over the past week, up 65.43% over the past month and up 69.76% over the past year. The price is below its 200-day moving average of $54.33.
Analysts' average 12-month price target for LQDA is $72.36, which implies 52.72% upside from the current price. Individual estimates range from $33.00 to $130.00.
Of the 8 analysts covering Liquidia Corporation, 2 rate it a strong buy, 4 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Liquidia Corporation has a market capitalization of $4.24B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Liquidia Corporation posted earnings of $0.74 per share against an estimate of $0.70, beating expectations by 5.71%. Upcoming reports are listed in the earnings calendar.
Liquidia Corporation reported revenue of $171.68M in its most recent quarter, which has increased by 1,842.73% compared with the same quarter a year earlier. Analysts had expected $168.48M.
Liquidia Corporation has not paid any dividends over the past year.
Companies most comparable to Liquidia Corporation include United Therapeutics Corporation, Insmed Incorporated, Avalyn Pharma Inc. Common Stock and Vicore Pharma Holding AB.
In the latest trading session LQDA moved between $43.24 and $51.11, a range of 16.62% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Liquidia Corporation shows a buy rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Liquidia Corporation is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks LQDA has traded between $22.31 and $93.61. The current price is 49.39% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.